Brain Tumor Reports

Volume 20 Number 9
September 2018


Home > Publications > Brain Tumor Reports > Volume 20, Year 2018 > Number 9, September



CONTENTS



BRAIN TUMORS

GLIOMAS
HIGH-GRADE GLIOMAS

DIFFUSE ASTROCYTIC AND OLIGODENDROGLIAL TUMORS
GLIOBLASTOMA

OTHER ASTROCYTIC TUMORS
PILOCYTIC ASTROCYTOMA

EMBRYONAL TUMORS
MEDULLOBLASTOMA

METASTATIC TUMORS





BRAIN TUMORS

.

Lapointe S, Perry A, Butowski NA.
Primary brain tumours in adults.
Lancet. 2018 Aug 4;392(10145):432-446. doi: 10.1016/S0140-6736(18)30990-5. Epub 2018 Jul 27.
Source | Full text | Similar articles



GLIOMAS

.

Blionas A, Giakoumettis D, Klonou A, Neromyliotis E, Karydakis P, Themistocleous MS.
Paediatric gliomas: diagnosis, molecular biology and management.
Ann Transl Med. 2018 Jun;6(12):251. doi: 10.21037/atm.2018.05.11.
Source | Full text | Similar articles



.

Picca A, Berzero G, Sanson M.
Current therapeutic approaches to diffuse grade II and III gliomas.
Ther Adv Neurol Disord. 2018 Jan 17;11:1756285617752039. doi: 10.1177/1756285617752039. eCollection 2018.
Source | Full text | Similar articles



HIGH-GRADE GLIOMAS


.

Artene SA, Turcu-Stiolica A, Ciurea ME, Folcuti C, Tataranu LG, Alexandru O, Purcaru OS, Tache DE, Boldeanu MV, Silosi C, Dricu A.
Comparative effect of immunotherapy and standard therapy in patients with high grade glioma: a meta-analysis of published clinical trials.
Sci Rep. 2018 Aug 7;8(1):11800. doi: 10.1038/s41598-018-30296-x.
Source | Full text | Similar articles



.

Jeck J, Kassubek R, Coburger J, Edenhofer S, Schönsteiner SS, Ludolph AC, Schmitz B, Engelke J, Mayer-Steinacker R, Lewerenz J, Bullinger L.
Bevacizumab in temozolomide refractory high-grade gliomas: single-centre experience and review of the literature.
Ther Adv Neurol Disord. 2018 Jan 21;11:1756285617753597. doi: 10.1177/1756285617753597. eCollection 2018.
Source | Full text | Similar articles



DIFFUSE ASTROCYTIC AND OLIGODENDROGLIAL TUMORS

.

Xie JC, Yang S, Liu XY, Zhao YX.
Marital status is associated with survival of patients with astrocytoma.
J Clin Neurosci. 2018 Jul 21. pii: S0967-5868(18)30421-1. doi: 10.1016/j.jocn.2018.07.005. [Epub ahead of print]
Source | Full text | Similar articles



GLIOBLASTOMA


.

Al Hassan M, Fakhoury I, El Masri Z, Ghazale N, Dennaoui R, El Atat O, Kanaan A, El-Sibai M.
Metformin Treatment Inhibits Motility and Invasion of Glioblastoma Cancer Cells.
Anal Cell Pathol (Amst). 2018 Jun 26;2018:5917470. doi: 10.1155/2018/5917470. eCollection 2018.
Source | Full text | Similar articles



.

AlHarbi M, Ali Mobark N, AlMubarak L, Aljelaify R, AlSaeed M, Almutairi A, Alqubaishi F, Hussain ME, Balbaid AAO, Said Marie A, AlSubaie L, AlShieban S, alTassan N, Ramkissoon SH, Abedalthagafi M.
Durable Response to Nivolumab in a Pediatric Patient with Refractory Glioblastoma and Constitutional Biallelic Mismatch Repair Deficiency.
Oncologist. 2018 Aug 13. pii: theoncologist.2018-0163. doi: 10.1634/theoncologist.2018-0163. [Epub ahead of print]
Source | Abstract | Similar articles



.

Choi JS, Berdis A.
Combating resistance to DNA damaging agents.
Oncoscience. 2018 Jun 24;5(5-6):134-136. doi: 10.18632/oncoscience.423. eCollection 2018 May.
Source | Full text | Similar articles



.

Jayamanne D, Wheeler H, Brazier D, Newey A, Kastelan M, Guo L, Back M.
Predicting patterns of failure in temporal lobe GBMs: possible implications on radiotherapy treatment portals.
Radiat Oncol. 2018 Jul 20;13(1):133. doi: 10.1186/s13014-018-1078-y.
Source | Full text | Similar articles



.

Le Rhun E, Genbrugge E, Stupp R, Chinot OL, Nabors LB, Cloughesy T, Reardon DA, Wick W, Gorlia T, Weller M.
Associations of anticoagulant use with outcome in newly diagnosed glioblastoma.
Eur J Cancer. 2018 Sep;101:95-104. doi: 10.1016/j.ejca.2018.06.029. Epub 2018 Jul 20.
Source | Full text | Similar articles



.

Lee C, Robinson M, Willerth SM.
Direct Reprogramming of Glioblastoma Cells into Neurons Using Small Molecules.
ACS Chem Neurosci. 2018 Aug 9. doi: 10.1021/acschemneuro.8b00365. [Epub ahead of print]
Source | Full text | Similar articles



.

Lee JH, Lee JE, Kahng JY, Kim SH, Park JS, Yoon SJ, Um JY, Kim WK, Lee JK, Park J, Kim EH, Lee JH, Lee JH, Chung WS, Ju YS, Park SH, Chang JH, Kang SG, Lee JH.
Human glioblastoma arises from subventricular zone cells with low-level driver mutations.
Nature. 2018 Aug;560(7717):243-247. doi: 10.1038/s41586-018-0389-3. Epub 2018 Aug 1.
Source | Full text | Similar articles



.

Lefranc F, Le Rhun E, Kiss R, Weller M.
Glioblastoma quo vadis: Will migration and invasiveness reemerge as therapeutic targets?
Cancer Treat Rev. 2018 Jul;68:145-154. doi: 10.1016/j.ctrv.2018.06.017. Epub 2018 Jun 26.
Source | Full text | Similar articles



.

Lombardi G.
Recent and ongoing clinical trials in glioblastoma.
Clin Adv Hematol Oncol. 2018 Jul;16(7):480-483.
Source | Full text | Similar articles



.

Lukas RV, Rodon J, Becker K, Wong ET, Shih K, Touat M, Fassò M, Osborne S, Molinero L, O'Hear C, Grossman W, Baehring J.
Clinical activity and safety of atezolizumab in patients with recurrent glioblastoma.
J Neurooncol. 2018 Aug 2. doi: 10.1007/s11060-018-2955-9. [Epub ahead of print]
Source | Full text | Similar articles



.

Marín-Ramos NI, Hofman FM, Chen TC.
NEO212: sub-cytotoxic doses capable of inhibiting glioma stem cell invasion.
Oncoscience. 2018 Jun 27;5(5-6):148-149. doi: 10.18632/oncoscience.429. eCollection 2018 May.
Source | Full text | Similar articles



.

Philips A, Henshaw DL, Lamburn G, O'Carroll MJ.
Brain Tumours: Rise in Glioblastoma Multiforme Incidence in England 1995-2015 Suggests an Adverse Environmental or Lifestyle Factor.
J Environ Public Health. 2018 Jun 24;2018:7910754. doi: 10.1155/2018/7910754. eCollection 2018.
Source | Full text | Similar articles



.

Philips A, Henshaw DL, Lamburn G, O'Carroll MJ.
Authors' Comment on "Brain Tumours: Rise in Glioblastoma Multiforme Incidence in England 1995-2015 Suggests an Adverse Environmental or Lifestyle Factor".
J Environ Public Health. 2018 Jun 25;2018:2170208. doi: 10.1155/2018/2170208. eCollection 2018.
Source | Full text | Similar articles



.

Wick W, Osswald M, Wick A, Winkler F.
Treatment of glioblastoma in adults.
Ther Adv Neurol Disord. 2018 Jul 25;11:1756286418790452. doi: 10.1177/1756286418790452. eCollection 2018.
Source | Full text | Similar articles



.

Yamaguchi S, Ishi Y, Motegi H, Okamoto M, Kobayashi H, Hirata K, Oda Y, Tanaka S, Terasaka S, Houkin K.
The prognostic improvement of add-on bevacizumab for progressive disease during concomitant temozolomide and radiation therapy in the patients with glioblastoma and anaplastic astrocytoma.
J Neurosurg Sci. 2018 Jul 9. doi: 10.23736/S0390-5616.18.04463-6. [Epub ahead of print]
Source | Abstract | Similar articles



OTHER ASTROCYTIC TUMORS

.

Lundar T, Due-Tønnessen BJ, Fric R, Due-Tønnessen P.
Postoperative radiotherapy for pediatric brain tumor: a lesson learned from treatment of a 5-year-old girl for posterior fossa astrocytoma (WHO1) in 1967.
Acta Neurochir (Wien). 2018 Jul 26. doi: 10.1007/s00701-018-3636-3. [Epub ahead of print]
Source | Full text | Similar articles



PILOCYTIC ASTROCYTOMA


.

Kondyli M, Larouche V, Saint-Martin C, Ellezam B, Pouliot L, Sinnett D, Legault G, Crevier L, Weil A, Farmer JP, Jabado N, Perreault S.
Trametinib for progressive pediatric low-grade gliomas.
J Neurooncol. 2018 Aug 10. doi: 10.1007/s11060-018-2971-9. [Epub ahead of print]
Source | Full text | Similar articles



EMBRYONAL TUMORS



MEDULLOBLASTOMA


.

Colafati GS, Voicu IP, Carducci C, Miele E, Carai A, Di Loreto S, Marrazzo A, Cacchione A, Cecinati V, Tornesello A, Mastronuzzi A.
MRI features as a helpful tool to predict the molecular subgroups of medulloblastoma: state of the art.
Ther Adv Neurol Disord. 2018 Jun 18;11:1756286418775375. doi: 10.1177/1756286418775375. eCollection 2018.
Source | Full text | Similar articles



.

Gits HC, Anderson M, Stallard S, Pratt D, Zon B, Howell C, Kumar-Sinha C, Vats P, Kasaian K, Polan D, Matuszak M, Spratt DE, Leonard M, Qin T, Zhao L, Leach J, Chaney B, Escorza NY, Hendershot J, Jones B, Fuller C, Leary S, Bartels U, Bouffet E, Yock TI, Robertson P, Mody R, Venneti S, Chinnaiyan AM, Fouladi M, Gottardo NG, Koschmann C.
Medulloblastoma therapy generates risk of a poorly-prognostic H3 wild-type subgroup of diffuse intrinsic pontine glioma: a report from the International DIPG Registry.
Acta Neuropathol Commun. 2018 Jul 26;6(1):67. doi: 10.1186/s40478-018-0570-9.
Source | Full text | Similar articles



.

Li Q, Dai Z, Cao Y, Wang L.
Comparing children and adults with medulloblastoma: a SEER based analysis.
Oncotarget. 2018 Jul 10;9(53):30189-30198. doi: 10.18632/oncotarget.23773. eCollection 2018 Jul 10.
Source | Full text | Similar articles



.

Nör C, Ramaswamy V.
Clinical and pre-clinical utility of genomics in medulloblastoma.
Expert Rev Neurother. 2018 Jul 26:1-15. doi: 10.1080/14737175.2018.1503536. [Epub ahead of print]
Source | Full text | Similar articles



.

Remke M, Ramaswamy V.
Infant medulloblastoma - learning new lessons from old strata.
Nat Rev Clin Oncol. 2018 Jul 20. doi: 10.1038/s41571-018-0071-6. [Epub ahead of print]
Source | Full text | Similar articles



METASTATIC TUMORS

.

Berghoff AS, Preusser M.
New developments in brain metastases.
Ther Adv Neurol Disord. 2018 Jun 28;11:1756286418785502. doi: 10.1177/1756286418785502. eCollection 2018.
Source | Full text | Similar articles



.

Hatiboglu MA, Akdur K, Sawaya R.
Neurosurgical management of patients with brain metastasis.
Neurosurg Rev. 2018 Jul 29. doi: 10.1007/s10143-018-1013-6. [Epub ahead of print]
Source | Full text | Similar articles